Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Of course. . . the algorithm that shows "no2" will reply to his
own post.. . .
1.5 Million ELTP shares @$0.024= $36K -Well within the scope of many an exhausted "retail" investor.
Now you gonna sell 'em because, well. . . Nasrat is Nasrat?
Monthly time-frame shows no "apparent" tax-loss selling.
Daily time frame reveals likely tax-loss selling.
"The right tool for the right job." Typical NO2
You should get some more due to someone's tax-loss selling.. . .
This does appear to be getting out of hand given that just days ago the price did manage to hit $0.04.. . . Given the current market, a "bounce" would not be unimaginable.
. . . Can ELTP close green?
" the current price is well earned."
Pauli Gualtieri would concur.
"Without question, today Elite would be valued differently". . .
. . . Given that the hype surrounding the pipe-dream that was Sequestox has been replaced by the mantra, "SLOW and steady". . .
. . . You guys at least got that right.
You could have doubled your money with ELTP. . .
. . . if you had sold 12 weeks ago.
There is nothing good about Nasrat Hakim. To put it
simply, it takes a real con-artist to say the things
Nasrat said and to not only fail to deliver on everything, but
to also make matters worse through underhanded dealings. It is
very doubtful shareholders will ever recover from an
association with Nasrat.
Thanks Doc. Now I just need to fix-up the Delorean's flux-capacitor.
"Old wolf knows what he is doing..."
-scratching his head wondering why he ever aborted the work with opioid ART when he sees what might have been possible with a bit of foresight and perseverance- Nasrat has none of the virtues of a wolf. Nasrat is a stupid, crooked, lazy, dullard of a cur.
Ugh! My man NAZ might very well be able to paper the walls of his cell with shares when he's "inside".. . . You gonna be applying for a 6-figure loan as well? I bet you have that loan application process down to a science. There is an area in which a number from this board may very truly excel.
The share price is a trifling matter of little consequence to Nasrat whose stature on the world-stage escapes the plebian minds of obviously misguided, ungrateful shareholders.. . . But not all.. . .
"Surely you jest! ". . . Why you are not on the fencing team.
Take it your keeping the rust off Excalibur there big guy, No?
"Nasrat has to retain the stated goal of going to the Nasdaq"
Umm. . . how about the part where he said unequivocally, "without a reverse-split"? . . .
While I have a sell order in the stratosphere -a bit over $0.10- in the event that the crookedness that caused it to spike before can crazily fixate upon it again for a day or so, I am resigned to seeing Nasrat's stratagem play out with shares at $0.004.. .. Perhaps a decade or 2 from now Harry Potter will take the helm and Elite will be Quiddich champions.
Where did the parties purported to be interested in buying the company that Nasrat spoke of several times long-ago go? . . .
Nasrat is a conjurer.
"So let me see if I understand..." -'Now that's surely a lost cause.. . .
Did not Nasrat himself announce that he would not be on conference-calls, only to yet be on the latest conference-call? The whole idea of conference-calls is rather "silly" to Nasrat, as in a way it conveys the false-hope to investors that someday they might get their money back. Well. . . that's kind of fun in a cruelly sadistic northern hew jersey pharmaceutical industry gangster kind of way. All but the "no2's" of the world would gladly see him go away as they are not cut from the same cloth as the not so petty, petty tyrant.
In fact on March 1, 2000 ELTP hit an all-time high of $24.00.
-Of course, you know this as you are always buying the shares other "savvy" investors miss. A question. . . Truthfully,. . . In all honesty. . . Ah, Forget it.
$24.00 per share! Now there's some grist for the dream-mill.. . . Tanqueray-and-Tonics on the fantail perhaps. Or are you a Bombay man?
Nasrat breaks new ground with his use of the term "silly" on a CC.
'no2koolaid'- For "extra-credit" (a term you are no doubt very familiar with, you might see if you can find any other conference-calls wherein the CEO used the term "silly". It is quite understandable for my man NAZ to tend away from all consideration of anything "serious". Enlighten us if you would, as certainly your intellectual domain encompasses all things deemed "silly".
-Thanks.
. . . Shouldn't you be accumulating at these prices?
"Buy the silly!" . . . "How far down the rabbit-hole do you want to go?"
New clothes. Same emperor.
With the arrival of Nasrat many moons ago, Elite Pharmaceuticals became a less than mediocre company with a much less than mediocre CEO, the purpose of which was thenceforth to provide a near effortless source of income for It's employees and management. And while the company does have a dwindling number of supporters, the "dwindling" may soon become a mad dash for the exits.
To "See what Nasrat has to say", start in upper left corner and move precipitously toward lower right. . . . You are currently invested in selling amphetamines to kids. Cheers!
Jinkies. . . Nasrat no doubt has a bounce in his step today, but nothing like the one I would like to give him.
Let's hope for some meaningful irrational exuberance this week.
Could you perhaps provide some insight into what exactly people mean when they say, "Nasrat sucks!" -Thanks. Cheers!
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2022 Financial Results on November 16, 2021
Financials for Second Quarter Fiscal Year 2022 Ended September 30, 2021 will be released November 15, 2021
NORTHVALE, NJ / ACCESSWIRE / November 9, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that the second quarter financial results of the 2022 fiscal year will be released on Monday, November 15, 2021. Elite's management will host a live conference call Tuesday, November 16 at 11:30 AM EST to discuss the company's financial and operating results and provide a general business update. Stockholders should submit questions to the company prior to the call.
Date: November 16, 2021
Time: 11:30 AM EST
Dial- in numbers: 1-800-346-7359 (domestic)
1-973-528-0008 (international)
Conference number: 98840
"We sit back and get the profit they do all the work. Cheers."
- Elite is always hiring like-minded individuals. You should get away from "Old Bill" and come to pastoral Northern New Jersey. Life is EASY at Elite Pharmaceuticals.
Appreciate the warning.
"I hope our leader is ok" . . . I hope YOUR leader didn't
kill someone while stealing a bicycle.
magic beans
With a Kamala Harris avatar nonetheless! I'll go out
on a limb and say I can safely assume you are O.K. with my
saying, "You go girl!" even if you are not technically female yet.
Correct me if I am wrong, but Nasrat and management have never purchased any shares on the open-market. . . Correct?
-They very well might deem such "counter-intuitive".
For Nasrat any business obligations are "disturbing".
You should use that vivid imagination to picture Nasrat Hakim laughing at your current predicament.. . . You've been "keepin' the faith" for about -25% now. "Cheers!"
Clearly, there are people on this board who deserve everything that ELTP ownership brings.. . . "Cheers!"
"NASDAQ2020". . . O.K.. That's in keeping with Nasrat's way of doing things.. . . Can we look forward to a name change after the New Year, i.e. "NASDAQ 2022"? . . . Wishful thinking. Maybe "NASDAQDreaming".
-And that would be because. . .
As your accomplice DNORWOOD states, "That Nasrat is smart, let the other guys do the work.". . . . You cheerleaders should take the field. Hey, at this point it's worth a try.. . .With that kind of attitude you both might go far at Elite.. . . I've provided a link;
"E-mail: careers@elitepharma.com"
" Will be rising today. Wait and see."
. . . That's O.K. Ya'll can stay in bed.